AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Occidental is one of the world's largest independent oil and gas producers. Its upstream operations are spread across the US, Middle East, and North Africa. It has a consolidated midstream business, ...

Wood ash can benefit some plants, such as tomatoes. Unfortunately, it can pose significant difficulties for blueberries if ...

Longan is a tropical fruit from the Sapindaceae family, closely related to lychee and rambutan. With its juicy, sweet texture ...

This came as part of the continuous regulatory surveillance, where drug samples are picked from sales/distribution points, ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...

The Straits Times zooms into local produce through a microscope, uncovering beauty that goes unnoticed. Find out how many of ...

Cool down with refreshing summer drinks! Stay hydrated and energized with the best thirst-quenching beverages. Enjoy healthy ...

A healthy range of blood potassium levels is 3.5 to 5.0 millimoles per liter of blood. Levels above this may indicate hyperkalemia, which occurs most often in people with chronic kidney disease.

Additionally, with the growing demand for chronic disease treatments and the ageing baby boomer population, the infusion market is set for significant growth. According to the market research ...